Publication | Closed Access

Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience

Psychoactive DrugNeurophysiologyMedicinePsychopharmacologyModulatory EffectPsychedelic TherapyNeuropharmacologyNeuroscienceBiological PsychiatryPsilocybin-induced Psychedelic ExperiencePsychedelic PharmacologyPharmacologyDopamineSocial Sciences5-Ht1a Agonist Buspirone